Genetic and environmental influences on factors associated with cardiovascular disease and the metabolic syndrome
- PMID: 19372593
- PMCID: PMC2724778
- DOI: 10.1194/jlr.P900033-JLR200
Genetic and environmental influences on factors associated with cardiovascular disease and the metabolic syndrome
Abstract
The relative influence of genetics and the environment on factors associated with cardiovascular disease (CVD) and metabolic syndrome (MetS) remains unclear. We performed model-fitting analyses to quantify genetic, common environmental, and unique environmental variance components of factors associated with CVD and MetS [waist circumference, blood pressure, fasting plasma glucose and insulin, homeostatic model assessment of insulin resistance (HOMA-IR), and fasting plasma lipids] in adult male and female monozygotic twins reared apart or together. We also investigated whether MetS components share common influences. Plasma cholesterol and triglyceride concentrations were highly heritable (56-77%, statistically significant). Waist circumference, plasma glucose and insulin, HOMA-IR, and blood pressure were moderately heritable (43-57%, statistically significant). Unique environmental factors contributed to the variance of all variables (20-38%, perforce statistically significant). Common environmental factors contributed 23, 30, and 42% (statistically significant) of the variance of waist circumference, systolic blood pressure, and plasma glucose, respectively. Two shared factors influenced MetS components; one influenced all components except HDL cholesterol, another influenced only lipid (triglyceride and HDL cholesterol) concentrations. These results suggest that genetic variance has a dominant influence on total variance of factors associated with CVD and MetS and support the proposal of one or more underlying pathologies of MetS.
Figures



References
-
- Lloyd-Jones D., Adams R., Carnethon M., De Simone G., Ferguson T. B., Flegal K., Ford E., Furie K., Go A., Greenlund K., et al. 2009. Heart disease and stroke statistics–2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 119: e21–e181. - PubMed
-
- Desroches S., Lamarche B. 2007. The evolving definitions and increasing prevalence of the metabolic syndrome. Appl. Physiol. Nutr. Metab. 32: 23–32. - PubMed
-
- Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. 2001. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 285: 2486–2497. - PubMed
-
- Govindarajan G., Whaley-Connell A., Mugo M., Stump C., Sowers J. R. 2005. The cardiometabolic syndrome as a cardiovascular risk factor. Am. J. Med. Sci. 330: 311–318. - PubMed
-
- Castro J. P., El-Atat F. A., McFarlane S. I., Aneja A., Sowers J. R. 2003. Cardiometabolic syndrome: pathophysiology and treatment. Curr. Hypertens. Rep. 5: 393–401. - PubMed
Publication types
MeSH terms
Grants and funding
- DK76092/DK/NIDDK NIH HHS/United States
- DK78867/DK/NIDDK NIH HHS/United States
- R37 DA018673/DA/NIDA NIH HHS/United States
- DK73321/DK/NIDDK NIH HHS/United States
- R01 DK076092/DK/NIDDK NIH HHS/United States
- DK79003/DK/NIDDK NIH HHS/United States
- R01 DK073321/DK/NIDDK NIH HHS/United States
- R01 DA018673/DA/NIDA NIH HHS/United States
- R01 MH065322/MH/NIMH NIH HHS/United States
- T32 HL069772/HL/NHLBI NIH HHS/United States
- DA18673/DA/NIDA NIH HHS/United States
- R21 DK078867/DK/NIDDK NIH HHS/United States
- MH65322/MH/NIMH NIH HHS/United States
- 5T32 HL069772/HL/NHLBI NIH HHS/United States
- DK046124/DK/NIDDK NIH HHS/United States
- R01 DK079003/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources